Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-13

Clinical Trial Update: Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes [EARLY_Phase 1]

View source ↗

Summary

EARLY Phase 1 trial evaluating metformin for microvascular dysfunction after gestational diabetes, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Anna Stanhewicz, PhD | Conditions: Gestational Diabetes | EARLY_Phase 1 | Status: RECRUITING